BCL-2 expression was also inhibited by the combination of melatonin and radiotherapy, thus enhancing the sensitivity of colon cancer cells to ionizing radiation [28] and increasing cell death in irradiated sarcoma cells [29]. The gene discussed is BCL2; the disease is malignant colon neoplasm.